Literature DB >> 17184938

Solid dispersions of itraconazole and enteric polymers made by ultra-rapid freezing.

Kirk A Overhoff1, Alejandro Moreno, Dave A Miller, Keith P Johnston, Robert O Williams.   

Abstract

The primary objective of the study is to investigate the influence of composition parameters including drug:polymer ratio and polymer type, and particle structure of enteric solid dispersions on the release of ITZ under sink and supersaturated dissolution conditions. Modulated differential scanning calorimetry (MDSC) was utilized to define the level of ITZ miscibility with each polymer. The compositions were completely miscible at 60% ITZ for both polymers and as high as 70% in HP-55. High potency composition glass transition temperatures (T(g)) correlated with predicted T(g)'s from the Gordon-Taylor equation, however, recrystallization exotherms revealed pure amorphous regions indicating that phase separation occurred during particle formation. Furthermore, in vitro studies including X-ray powder diffraction (XRD), scanning electron microscopy (SEM), surface area analysis (BET), and dissolution were performed to determine differences between low potency (completely miscible) and high potency (partially miscible) compositions. Dissolution studies on low potency ITZ compositions revealed that miscibility plays an active role in ITZ release under sink conditions, and square root diffusion through the enteric polymer is observed. Supersaturated dissolution profiles revealed high potency compositions had maximum saturation levels (C/Ceq(max)) between 10.6- and 8-times equilibrium solubility, but had higher cumulative extents of supersaturation, compared to low potency compositions which had C/Ceq(max) values of 15-19.6. However, these low potency compositions rapidly precipitated leading to significantly lower AUCs (p<0.05). The change in the miscibility of the solid dispersion had a pronounced effect of drug release (sink) while differences in potency influenced supersaturated dissolution profiles.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17184938     DOI: 10.1016/j.ijpharm.2006.11.043

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  10 in total

1.  Modified release itraconazole amorphous solid dispersion to treat Aspergillus fumigatus: importance of the animal model selection.

Authors:  Julien P Maincent; Laura K Najvar; William R Kirkpatrick; Siyuan Huang; Thomas F Patterson; Nathan P Wiederhold; Jay I Peters; Robert O Williams
Journal:  Drug Dev Ind Pharm       Date:  2016-10-05       Impact factor: 3.225

2.  Screening methodologies for the development of spray-dried amorphous solid dispersions.

Authors:  Íris Duarte; José Luís Santos; João F Pinto; Márcio Temtem
Journal:  Pharm Res       Date:  2014-08-19       Impact factor: 4.200

Review 3.  Solid dispersion technology as a formulation strategy for the fabrication of modified release dosage forms: A comprehensive review.

Authors:  Kaushika Patel; Shreeraj Shah; Jaymin Patel
Journal:  Daru       Date:  2022-04-18       Impact factor: 4.088

4.  Targeted intestinal delivery of supersaturated itraconazole for improved oral absorption.

Authors:  Dave A Miller; James C DiNunzio; Wei Yang; James W McGinity; Robert O Williams
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

5.  Hot melt extrusion as an approach to improve solubility, permeability and oral absorption of a psychoactive natural product, piperine.

Authors:  Eman A Ashour; Soumyajit Majumdar; Abdulla Alsheteli; Sultan Alshehri; Bader Alsulays; Xin Feng; Andreas Gryczke; Karl Kolter; Nigel Langley; Michael A Repka
Journal:  J Pharm Pharmacol       Date:  2016-06-10       Impact factor: 3.765

6.  A novel domperidone hydrogel: preparation, characterization, pharmacokinetic, and pharmacodynamic properties.

Authors:  Chun-Hui Zhang; Bing-Xiang Zhao; Yue Huang; Ying Wang; Xi-Yu Ke; Bo-Jun Zhao; Xuan Zhang; Qiang Zhang
Journal:  J Drug Deliv       Date:  2011-02-20

7.  A Novel Protocol Using Small-Scale Spray-Drying for the Efficient Screening of Solid Dispersions in Early Drug Development and Formulation, as a Straight Pathway from Screening to Manufacturing Stages.

Authors:  Aymeric Ousset; Rosanna Chirico; Florent Robin; Martin Alexander Schubert; Pascal Somville; Kalliopi Dodou
Journal:  Pharmaceuticals (Basel)       Date:  2018-08-27

8.  Enhanced dissolution and stability of Tanshinone IIA base by solid dispersion system with nano-hydroxyapatite.

Authors:  Yan-Rong Jiang; Zhen-Hai Zhang; Sai-Yan Huang; Yan Lu; Tian-Tian Ma; Xiao-Bin Jia
Journal:  Pharmacogn Mag       Date:  2014-07       Impact factor: 1.085

9.  Potential of solid dispersions to enhance solubility, bioavailability, and therapeutic efficacy of poorly water-soluble drugs: newer formulation techniques, current marketed scenario and patents.

Authors:  Sultan Alshehri; Syed Sarim Imam; Afzal Hussain; Mohammad A Altamimi; Nabil K Alruwaili; Fahad Alotaibi; Abdullah Alanazi; Faiyaz Shakeel
Journal:  Drug Deliv       Date:  2020-11-09       Impact factor: 6.419

Review 10.  Insoluble Polymers in Solid Dispersions for Improving Bioavailability of Poorly Water-Soluble Drugs.

Authors:  Thao T D Tran; Phuong H L Tran
Journal:  Polymers (Basel)       Date:  2020-07-28       Impact factor: 4.329

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.